2,876
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Brain targeting efficiency of intranasal clozapine-loaded mixed micelles following radio labeling with Technetium-99m

ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 1524-1538 | Received 26 May 2021, Accepted 28 Jun 2021, Published online: 16 Jul 2021

References

  • Abd-Elal R, Shamma R, Rashed HM, Bendas ER. (2016). Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency. Drug Deliv 23:1–29.
  • Abdelbary GA, Tadros MI. (2013). Brain targeting of olanzapine via intranasal delivery of core–shell difunctional block copolymer mixed nanomicellar carriers: in vitro characterization, ex vivo estimation of nasal toxicity and in vivo biodistribution studies. Int J Pharm 452:300–10.
  • Abdelrahman Y, Fararjeh M, Abdel-Razeq W, et al. (2013). Assessment of possible immunotoxicity of the antipsychotic drug clozapine. J Pharm Pharmacol 66:378–86.
  • Agrawal A, Maheshwari RK. (2011). Formulation development and evaluation of in situ nasal gel of poorly water soluble drug using mixed solvency concept. Asian J Pharm 5:131.
  • Ahmed S, Kassem MA, Sayed S, et al. (2020). Bilosomes as promising nanovesicular carriers for improved transdermal delivery: construction, in vitro optimization, ex vivo permeation and in vivo evaluation. Int J Nanomedicine 15:9783–98.
  • Ahmed S, Kassem MA, Sayed S, et al. (2021). Co-polymer mixed micelles enhanced transdermal transport of lornoxicam: in vitro characterization, and in vivo assessment of anti-inflammatory effect and antinociceptive activity. J Drug Deliv Sci Technol 62:102365.
  • Al-Saraj A. (2010). Use of saturated sodium chloride solution as a tissue fixative. J Vet Sci 24:53–8.
  • Alvarez-Lorenzo C, Rey-Rico A, Sosnik A, et al. (2010). Poloxamine-based nanomaterials for drug delivery. Front Biosci (Elite Ed) 2:424–40.
  • Annadurai G, Ling LY, Lee J-F, et al. (2008). Statistical optimization of medium components and growth conditions by response surface methodology to enhance phenol degradation by Pseudomonas putida. J Hazard Mater 151:171–8.
  • Araújo J, Vega E, Lopes C, et al. (2009). Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres. Colloids Surf B Biointerfaces 72:48–56.
  • Babkina AS, Golubev AM, Sundukov DV, et al. (2018). Clozapine: mechanisms of toxicity and side effects. Gen Reanimatol 14:35–45.
  • Barlow RJ, Zimmerman S, Khougaz K, et al. (1996). Phase separation of micellar solutions at extreme dilution: a study of polystyrene-b-poly(sodium acrylate) micelles in aqueous NaCl solutions. J Polym Sci B Polym Phys 34:1197–212.
  • Batrakova E, Bronich T, Vetro JA, Kabanov AV. (2006). Polymer micelles as drug carriers. In Torchilin, V. P., (ed.) Nanoparticulates as Drug Carriers. London, UK: Imperial College Press, 57–95.
  • Chaudhari S, Jayashree RP. (2014). Study of block copolymer micelles as vehicles for hydrophobic drug lamotrigine. Indian J Pharm Educ Res 48:55–66.
  • Chen F, Rice KC, Liu X-M, et al. (2010). Triclosan-loaded tooth-binding micelles for prevention and treatment of dental biofilm. Pharm Res 27:2356–64.
  • Chiappetta DA, Facorro G, de Celis ER, et al. (2011). Synergistic encapsulation of the anti-HIV agent efavirenz within mixed poloxamine/poloxamer polymeric micelles. Nanomedicine 7:624–37.
  • De Berardis D, Rapini G, Olivieri L, et al. (2018). Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine. Ther Adv Drug Saf 9:237–56.
  • Dimitrijevic I, Pantic I. (2014). Application of nanoparticles in psychophysiology and psychiatry research. Rev Adv Mater Sci 38:1–6.
  • Du G, Gao Y, Nie S, et al. (2006). The permeation of nalmefene hydrochloride across different regions of ovine nasal mucosa. Chem Pharm Bull 54:1722–4.
  • Eiler WJA, 2nd, Gleason SD, Smith JL, Witkin JM. (2019). A medium throughput rodent model of relapse from addiction with behavioral and pharmacological specificity. Pharmacol Biochem Behav 183:72–9.
  • Elsayed I, Sayed S. (2017). Tailored nanostructured platforms for boosting transcorneal permeation: Box–Behnken statistical optimization, comprehensive in vitro, ex vivo and in vivo characterization. Int J Nanomedicine 12:7947–62.
  • El-Setouhy DA, Ibrahim AB, Amin MM, et al. (2016). Intranasal haloperidol-loaded miniemulsions for brain targeting: evaluation of locomotor suppression and in-vivo biodistribution. Eur J Pharm Sci 92:244–54.
  • Fahmy AM, El-Setouhy DA, Ibrahim AB, et al. (2018). Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies. Drug Deliv 25:12–22.
  • Ganger S, Schindowski K. (2018). Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa. Pharmaceutics 10:116.
  • Geskovski N, Kuzmanovska S, Simonoska Crcarevska M, et al. (2013). Comparative biodistribution studies of technetium-99 m radiolabeled amphiphilic nanoparticles using three different reducing agents during the labeling procedure. J Labelled Comp Radiopharm 56:689–95.
  • Habib BA, Sayed S, Elsayed GM, et al. (2018). Enhanced transdermal delivery of ondansetron using nanovesicular systems: fabrication, characterization, optimization and ex-vivo permeation study—Box–Cox transformation practical example. Eur J Pharm Sci 115:352–61.
  • Hall AV, Solanki KK, Vinjamuri S, et al. (1998). Evaluation of the efficacy of 99mTc-Infecton, a novel agent for detecting sites of infection. J Clin Pathol 51:215–9.
  • Ibrahim AB, Sakr TM, Khoweysa OMA, et al. (2014). Formulation and preclinical evaluation of 99mTc–gemcitabine as a novel radiopharmaceutical for solid tumor imaging. J Radioanal Nucl Chem 302:179–86.
  • Jagtap P, Jadhav K, Dand N. (2015). Formulation and ex vivo evaluation of solid lipid nanoparticles (SLNS) based hydrogel for intranasal drug delivery. World Acad Sci Eng Technol Int J Bioeng Life Sci 9:43–53.
  • Jain R, Nabar S, Dandekar P, et al. (2010). Micellar nanocarriers: potential nose-to-brain delivery of zolmitriptan as novel migraine therapy. Pharm Res 27:655–64.
  • Jain V, Prasad D, Jain D, et al. (2011). Factorial design-based development of measlamine microspheres for colonic delivery. Biomatter 1:182–8.
  • Jönsson L, Simonsen J, Brain C, et al. (2019). Identifying and characterizing treatment-resistant schizophrenia in observational database studies. Int J Methods Psychiatr Res 28:e1778.
  • Juggernauth KA, Gros AE, Meznarich NAK, et al. (2011). In situ photogelation kinetics of laponite nanoparticle-based photorheological dispersions. Soft Matter 7:10108–15.
  • Kahn RS, Sommer IE, Murray RM, et al. (2015). Schizophrenia. Nat Rev Dis Primers 1:15067.
  • Kesby JP, Eyles DW, McGrath JJ, et al. (2018). Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience. Transl Psychiatry 8:30.
  • Kolsure PK, Rajkapoor B. (2012). Development of zolmitriptan gel for nasal administration. Asian J Pharm Clin Res 5:88–94.
  • Kulthe SS, Inamdar NN, Choudhari YM, et al. (2011). Mixed micelle formation with hydrophobic and hydrophilic Pluronic block copolymers: implications for controlled and targeted drug delivery. Colloids Surf B Biointerfaces 88:691–6.
  • Kumar N, Gupta GD, Arora D. (2021). DoE directed optimization, development and characterization of resveratrol loaded Nlc system for the nose to brain delivery in the management of glioblastoma multiforme. Durham, North Carolina: Research Square.
  • Kumar P, Mohan C, Kanamsrinivasan Uma Shankar M, et al. (2011). Physiochemical characterization and release rate studies of solid dispersions of ketoconazole with Pluronic F127 and PVP K-30. Iran J Pharm Res 10:685–94.
  • Lee ES, Oh YT, Youn YS, et al. (2011). Binary mixing of micelles using Pluronics for a nano-sized drug delivery system. Colloids Surf B Biointerfaces 82:190–5.
  • Lee J, Kim M-G, Jeong H-C, et al. (2021). Physiologically-based pharmacokinetic model for clozapine in Korean patients with schizophrenia. Transl Clin Pharmacol 29:33–44.
  • Leyva-Gomez G, Gonzalez-Trujano ME, López-Ruiz E, et al. (2014). Nanoparticle formulation improves the anticonvulsant effect of clonazepam on the pentylenetetrazole-induced seizures: behavior and electroencephalogram. J Pharm Sci 103:2509–19.
  • Liu J-S, Wang J-H, Zhou J, et al. (2014). Enhanced brain delivery of lamotrigine with Pluronic(®) P123-based nanocarrier. Int J Nanomedicine 9:3923–35.
  • Łukasiewicz S, Błasiak E, Szczepanowicz K, et al. (2017). The interaction of clozapine loaded nanocapsules with the hCMEC/D3 cells – in vitro model of blood brain barrier. Colloids Surf B Biointerfaces 159:200–10.
  • Łukasiewicz S, Mikołajczyk A, Szczęch M, et al. (2019). Encapsulation of clozapine into polycaprolactone nanoparticles as a promising strategy of the novel nanoformulation of the active compound. J Nanopart Res 21:149.
  • Madhuri K. (2014). Formulation and evaluation of clozapine solid lipid nanoparticles with natural lipid. J Drug Discov Ther 2:18–26.
  • Motaleb MA, El-Kolaly MT, Ibrahim AB, et al. (2011). Study on the preparation and biological evaluation of 99mTc–gatifloxacin and 99mTc–cefepime complexes. J Radioanal Nucl Chem 289:57–65.
  • Nour SA, Abdelmalak NS, Naguib MJ, et al. (2016). Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies. Drug Deliv 23:1–15.
  • Owen SC, Chan DPY, Shoichet MS, et al. (2012). Polymeric micelle stability. Nano Today 7:53–65.
  • Panda A, Meena J, Katara R, Majumdar DK. (2014). Formulation and characterization of clozapine and risperidone co-entrapped spray-dried PLGA nanoparticles. Pharm Dev Technol 21:43–53.
  • Patel HP, Chaudhari PS, Gandhi PA, et al. (2021). Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: optimization and in vivo pharmacokinetic studies. Int J Pharm 600:120474.
  • Patel HP, Gandhi PA, Chaudhari PS, et al. (2021). Clozapine loaded nanostructured lipid carriers engineered for brain targeting via nose-to-brain delivery: optimization and in vivo pharmacokinetic studies. J Drug Deliv Sci Technol 102533.
  • Patel KR, Cherian J, Gohil K, et al. (2014). Schizophrenia: overview and treatment options. P T 39:638–45.
  • Patel V, Ray D, Bahadur A, et al. (2018). Pluronic®-bile salt mixed micelles. Colloids Surf B Biointerfaces 166:119–26.
  • Piazzini V, D’Ambrosio M, Luceri C, et al. (2019). Formulation of nanomicelles to improve the solubility and the oral absorption of silymarin. Molecules 24:1688.
  • Privalova AM, Gulyaeva NV, Bukreeva TV, et al. (2012). Intranasal administration: a prospective drug delivery route to the brain. Neurochem J 6:77–88.
  • Qi P, Muddukrishna SN, Torok-Both R, et al. (1996). Direct 99mTc-labeling of antibodies by sodium dithionite reduction, and role of ascorbate as a stabilizer in cysteine challenge. Nucl Med Biol 23:827–35.
  • Rashed HM, Shamma RN, Basalious EB, et al. (2016). Contribution of both olfactory and systemic pathways for brain targeting of nimodipine-loaded lipo-pluronics micelles: in vitro characterization and in vivo biodistribution study after intranasal and intravenous delivery. Drug Deliv 24:181–7.
  • Rey-Rico A, Cucchiarini M. (2018). PEO-PPO-PEO tri-block copolymers for gene delivery applications in human regenerative medicine—an overview. Int J Mol Sci 19:775.
  • Ribeiro A, Sosnik A, Chiappetta DA, et al. (2012). Single and mixed poloxamine micelles as nanocarriers for solubilization and sustained release of ethoxzolamide for topical glaucoma therapy. J R Soc Interface 9:2059–69.
  • Sakr TM, Ibrahim AB, Fasih TW, et al. (2017). Preparation and biological profile of 99mTc–lidocaine as a cardioselective imaging agent using 99mTc eluted from 99Mo/99mTc generator based on Al–Mo gel. J Radioanal Nucl Chem 314:2091–8.
  • Salama AH, Shamma RN. (2015). Tri/tetra-block co-polymeric nanocarriers as a potential ocular delivery system of lornoxicam: in-vitro characterization, and in-vivo estimation of corneal permeation. Int J Pharm 492:28–39.
  • Salama HA, Mahmoud AA, Kamel AO, et al. (2012). Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route. Colloids Surf B Biointerfaces 100:146–54.
  • Sayed S, Abdel-Moteleb M, Amin MM, et al. (2021). Cubogel as potential platform for glaucoma management. Drug Deliv 28:293–305.
  • Sayed S, Elsayed I, Ismail MM, et al. (2018). Optimization of β-cyclodextrin consolidated micellar dispersion for promoting the transcorneal permeation of a practically insoluble drug. Int J Pharm 549:249–60.
  • Sayed S, Habib BA, Elsayed GM. (2017). Tri-block co-polymer nanocarriers for enhancement of oral delivery of felodipine: preparation, in-vitro characterization and ex-vivo permeation. J Liposome Res 28:1–39.
  • Sayed S, Abdelmoteleb M, Amin MM, et al. (2020). Effect of formulation variables and gamma sterilization on transcorneal permeation and stability of proniosomal gels as ocular platforms for antiglaucomal drug. AAPS PharmSciTech 21:87.
  • Seeman P. (2014). Clozapine, a fast-off-D2 antipsychotic. ACS Chem Neurosci 5:24–9.
  • Serralheiro A, Alves G, Fortuna A, et al. (2014). Intranasal administration of carbamazepine to mice: a direct delivery pathway for brain targeting. Eur J Pharm Sci 60:32–9.
  • Shafaat K, Kumar B, Das SK, Ul Hasan R. (2013). Novel nanoemulsion as vehicles for transdermal delivery of clozapine: in vitro and in vivo studies. Int J Pharm Pharm Sci 5:126–34.
  • Shaik N. (2015). Solubility enhancement of clozapine using super disintegrants by solid dispersion methods. Int J Pharm 1:32–88.
  • Shamsel-Din H, Ibrahim A. (2017). A novel radiolabeled indole derivative as solid tumor imaging agent: in silico and preclinical pharmacological study. J Radioanal Nucl Chem 314:2263–9.
  • Singla P, Singh O, Chabba S, et al. (2018). Sodium deoxycholate mediated enhanced solubilization and stability of hydrophobic drug clozapine in pluronic micelles. Spectrochim Acta A Mol Biomol Spectrosc 191:143–54.
  • Tambosi G, Coelho PF, Luciano S, et al. (2018). Challenges to improve the biopharmaceutical properties of poorly water-soluble drugs and the application of the solid dispersion technology. Matéria 23.
  • Tareen FK, Shah KU, Ahmad N, et al. (2020). Proniosomes as a carrier system for transdermal delivery of clozapine. Drug Dev Ind Pharm 46:946–54.
  • Vandekerckhove A, Glorieux S, Broeck WVd, et al. (2009). In vitro culture of equine respiratory mucosa explants. Vet J 181:280–7.
  • Vieira SM, Michels LR, Roversi K, et al. (2016). A surface modification of clozapine-loaded nanocapsules improves their efficacy: a study of formulation development and biological assessment. Colloids Surf B Biointerfaces 145:748–56.
  • Vyas B, Pillai S, Bahadur A, et al. (2018). A comparative study on micellar and solubilizing behavior of three EO–PO based star block copolymers varying in hydrophobicity and their application for the in vitro release of anticancer drugs. Polymers 10:76.
  • Willner K, Vasan S, Abdijadid S. (2019). Atypical antipsychotic agents. Treasure Island, FL: StatPearls.
  • Xiuli L, Jian X, Wanguo H, et al. (2004). Effect of additives on the cloud points of two tri-block copolymers in aqueous solution. Colloids Surf A Physicochem Eng Asp 237:1–6.
  • Younes NF, Abdel-Halim SA, Elassasy AI, et al. (2018). Corneal targeted sertaconazole nitrate loaded cubosomes: preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies. Int J Pharm 553:386–97.